Ghosh, Sayan
Padmanabhan, Archana
Vaidya, Tanuja
Watson, Alan M.
Bhutto, Imran A.
Hose, Stacey
Shang, Peng
Stepicheva, Nadezda
Yazdankhah, Meysam
Weiss, Joseph
Das, Manjula
Gopikrishna, Santosh
Aishwarya,
Yadav, Naresh
Berger, Thorsten
Mak, Tak W.
Xia, Shuli
Qian, Jiang
Lutty, Gerard A.
Jayagopal, Ashwath
Zigler, J. Samuel Jr
Sethu, Swaminathan
Handa, James T.
Watkins, Simon C. http://orcid.org/0000-0003-4092-1552
Ghosh, Arkasubhra http://orcid.org/0000-0002-6570-5891
Sinha, Debasish
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Eye Institute (EY019037-S)
Research to Prevent Blindness
Roche
Article History
Received: 18 February 2019
Accepted: 27 August 2019
First Online: 20 September 2019
Competing interests
: A.J. and D.S. are inventors in a US patent filed by F. Hoffmann-La Roche, Ltd., Basel, Switzerland on an AKT2 inhibitor for treatment of dry AMD. The remianing authors declare no competing interests.